Ketamine Therapy for Grief: Science, Safety & Hope

Grief is supposed to soften over time. But for some people, it doesn't. Months pass, then a year, and the pain stays as sharp as it was in the beginning. You've tried therapy, maybe medication, yet you still can't move forward. This isn't your fault. Some grief simply doesn't respond to standard treatments.

Nearly half of people who try specialized grief therapy don't get adequate relief. For them, ketamine has emerged as a potential option—not for grief itself, but for the symptoms that often accompany it.

Here's what you need to know upfront: Ketamine doesn't treat grief directly. No clinical trials support it as a primary grief treatment. However, ketamine may provide rapid relief for treatment-resistant depression, PTSD, and anxiety that commonly accompany prolonged grief. About 70% of people with complicated grief have at least one additional psychiatric condition. Addressing these symptoms creates space for the grief work that therapy provides.

What Is Prolonged Grief Disorder?

Prolonged Grief Disorder (PGD) is a formally recognized psychiatric condition—intense, persistent grief reactions that don't diminish over time the way normal grief does. It's now included in the DSM-5 as a distinct diagnosis, separate from depression or normal bereavement.

Roughly 8.5% of bereaved adults develop PGD. Certain losses carry higher risk: parents who've lost a child face rates as high as 40%, while bereaved spouses develop PGD at around 34%.

The critical distinction: Normal grief comes in waves that gradually become less frequent. You reengage with life over time. PGD involves persistent, daily symptoms that prevent you from resuming meaningful activities and relationships, even a year or more after the loss.

Traditional Treatments for Prolonged Grief & Their Limitations

Complicated Grief Treatment (CGT) is the gold-standard approach. A landmark JAMA trial showed a 51% response rate, better than generic psychotherapy, but still leaving nearly half without adequate relief. The treatment involves 16 weekly sessions of exposure work, social support rebuilding, and narrative reconstruction.

Exposure-based cognitive behavioral therapy shows higher response rates in some studies, with up to 83% at six-month follow-up. But access to trained therapists remains limited in many communities.

A critical finding: Prolonged grief disorder doesn't respond to antidepressants. PGD is neurobiologically distinct from major depression, even when depression accompanies it. For people who don't respond to CGT or can't access specialized care, these limitations explain why alternative approaches warrant consideration.

How Does Ketamine Therapy for Grief Work?

Traditional antidepressants adjust serotonin levels over weeks. Ketamine works differently: it blocks NMDA receptors, brain switches that control learning and memory. The blockade triggers a glutamate surge that activates growth pathways, increasing BDNF—a protein that helps repair neural connections. Effects last at least 72 hours. The speed matters.

Ketamine's mechanisms are well-established for treating depression and PTSD, which commonly co-occur with prolonged grief. About 34% of people with PGD also experience PTSD, with rates varying by how the loss occurred.

Prolonged grief has distinct neurobiological features compared to depression: unique patterns of reward system activation and emotional processing. While rigorous clinical trials in grief populations are lacking, ketamine's effects on co-occurring depression and trauma symptoms are well-documented. Results come fast. Many studies report significant symptom improvement within 24 hours.

If you're experiencing prolonged grief alongside depression or PTSD, ketamine may provide relief from those conditions. The rapid effects create psychological capacity for the grief work that therapy provides.

What Does the Research Show?

The honest answer: Direct clinical research on ketamine for grief barely exists.

The earliest and most-cited clinical literature consists of a 2016 case report describing a single patient with complicated grief treated with ketamine. The authors highlighted therapeutic potential, though subsequent research specifically focused on complicated grief remains scarce.

No randomized controlled trials exist. Only minimal case series data. No FDA approval for grief treatment. No standardized protocols for grief-specific dosing.

What we do know:

Esketamine (Spravato) has FDA approval for treatment-resistant depression. Research also shows significant PTSD symptom reduction, though no controlled trials examine ketamine specifically for grief. Among people with prolonged grief who also have treatment-resistant depression, esketamine has shown response rates around 50%.

For people bereaved by violence, PTSD rates can reach 34%. Ketamine has shown promise in preliminary studies for short-term symptom reduction in these populations. However, meta-analyses don't confirm consistent 24-hour benefit compared to placebo, and the evidence base remains early.

What Are the Risks of Ketamine Therapy for Grief?

Most side effects of ketamine therapy resolve within two hours. During sessions, you might experience a floating sensation, dissociation, mild nausea, dizziness, or blood pressure increases. Dissociation occurs in at least 5% of people at more than twice the rate of placebo.

Blood pressure changes require particular attention for older adults or those with pre-existing hypertension. A 2017 study found all participants with hypertension experienced blood pressure increases during infusion, with age significantly increasing this risk.

Considerations for people who are grieving:

For people processing grief, dissociative experiences raise unexamined questions. Research in trauma populations shows mixed findings: some studies report only transient dissociation, while others note clinically significant increases. Grief-specific data is largely absent. The gaps represent genuine unknowns rather than documented harms, but they underscore why ketamine for grief targets accompanying symptoms rather than the grief process itself.

Given that 22–27% of people with probable PGD experience suicidal ideation, enhanced monitoring may be necessary.

Ketamine may not be appropriate if you have:

• Aneurysmal vascular disease
• Arteriovenous malformation
• History of intracerebral hemorrhage
• Hypersensitivity to ketamine or esketamine
• Pregnancy
• Uncontrolled hypertension or cardiovascular instability
• History of psychosis or active substance use disorder

Innerwell provides comprehensive screening, licensed clinician oversight, and integration therapy to support your care. Ketamine therapy is typically considered when traditional approaches haven't provided sufficient relief for grief-related depression or trauma symptoms.

How Innerwell's Ketamine Therapy Approach Works for Grief?

You don't have to navigate this alone. When standard treatments haven't addressed the depression, anxiety, or trauma symptoms that commonly accompany grief, Innerwell's at-home program provides relief alongside comprehensive therapeutic support.

The FDA has expressed concerns about unsupervised at-home ketamine use. Innerwell addresses this through comprehensive psychiatric evaluation, guidance from licensed clinicians, and structured integration therapy. At-home convenience doesn't compromise clinical safety.

The journey unfolds through several key phases:

1. Virtual psychiatric evaluation. You begin with a comprehensive telehealth assessment where specialists review your grief history, accompanying symptoms, previous treatment responses, and safety considerations. This evaluation ensures ketamine treatment is appropriate for your situation.
2. At-home ketamine sessions. If clinically appropriate, sublingual ketamine tablets ship securely to your door. You'll receive precise dosing instructions and guidance for your sessions at home, with clinical support available throughout.
3. Telehealth integration therapy. Licensed therapists guide you through preparation before each session and help you process insights afterward. Integration provides the grief-specific psychological work that ketamine alone can't address.
4. Ongoing virtual monitoring and support. Throughout your care, the platform tracks changes in depression, anxiety, and trauma-related symptoms. Your team can adjust dosing or recommend complementary approaches based on your response.

Every Innerwell patient begins with a comprehensive evaluation to ensure proper preparation and safety protocols.

Is Ketamine Therapy for Grief Right for Me?

If you've tried grief therapy and continue struggling with debilitating depression, anxiety, or PTSD symptoms, ketamine may offer relief for these co-occurring conditions. Esketamine has FDA approval for persistent depression, and research demonstrates significant efficacy for PTSD symptoms. However, ketamine targets these accompanying symptoms, not the grief process itself.

You're likely a good fit if depression, anxiety, or trauma symptoms persist alongside your grief despite standard treatments, or if grief therapies haven't provided adequate relief. The ideal candidate understands that ketamine addresses accompanying symptoms while still engaging in grief-focused therapy to process the loss. Symptom relief creates space for that work.

Certain medical conditions detailed in the Risks section may rule out treatment. Every patient begins with a comprehensive evaluation ensuring ketamine is both safe and likely to provide relief.

Try Ketamine Therapy for Grief With Innerwell

When standard treatments haven't addressed the depression, anxiety, or trauma symptoms that commonly accompany grief, ketamine offers a different path through glutamate pathways and neuroplasticity. These mechanisms provide rapid relief from debilitating symptoms that may have kept you stuck for months or years.

With Innerwell, you get clinical oversight, sublingual ketamine delivered to your home, personalized therapy sessions, and real-time progress monitoring. Ketamine therapy is considered after standard grief-specific treatments have been tried without adequate relief.

Take our free assessment to see if ketamine therapy might help with the depression, anxiety, or PTSD symptoms accompanying your grief.

Frequently Asked Questions About Ketamine Therapy for Grief

Is ketamine therapy for grief legal?

Yes. Ketamine is an FDA-approved Schedule III medication that clinicians can prescribe off-label for conditions such as depression, anxiety, and PTSD symptoms. Innerwell adheres to state and federal telemedicine regulations and follows FDA safety guidance for compounded ketamine products.

Can ketamine treat grief directly?

No. Current evidence doesn't support ketamine as a treatment for grief itself. Ketamine addresses accompanying depression, anxiety, and PTSD symptoms, not the grief process. See the sections above for detailed explanation.

How long does it take for ketamine therapy to work?

Results come fast. Ketamine demonstrates rapid effects on accompanying depression and PTSD symptoms. Benefits often appear within 24 hours rather than the weeks required for traditional antidepressants. Integration therapy provides the grief-specific psychological work that ketamine alone can't address.

How long do the effects last?

Duration varies significantly by individual. Some people experience benefits that persist beyond the initial treatment period, though the research base for grief populations remains limited. Maintenance sessions help sustain benefits over time. Innerwell creates personalized maintenance plans based on your symptom patterns and clinical presentation.

Is ketamine therapy for grief covered by insurance?

Because it's off-label, ketamine treatment for complicated grief may not be covered by insurance, as policies vary by insurer and state. Check with your insurance provider for specific coverage details.